Picture of Central Garden & Pet logo

CENTA — Central Garden & Pet News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesBalancedMid CapSuper Stock

Central Garden & Pet Q3 sales miss estimates on exit of pet distribution; lifts FY forecast

Central Garden & Pet Q3 sales miss estimates on exit of pet distribution; lifts FY forecast


Overview

  • U.S. pet and garden goods maker's preliminary fiscal Q3 net sales fell 8%, missing analyst expectations

  • GAAP diluted EPS for fiscal Q3 declined to $1.45 from $1.52 a year ago

  • Company raised fiscal 2026 non-GAAP EPS outlook and agreed to acquire 80% of TRIXIE


Outlook

  • Central Garden & Pet raises fiscal 2026 non-GAAP diluted EPS outlook to $2.85 or better

  • Company projects fiscal 2026 capital expenditures of about $50 mln

  • Outlook assumes competitive retail environment, value-oriented consumers, and inflation in select commodities


Result Drivers

  • BUSINESS EXIT IMPACT - Co said overall sales decline was primarily due to exit of pet distribution business, while organic sales grew 2%

  • MARGIN IMPROVEMENT - Co attributed margin expansion to exit of pet distribution business and disciplined execution

  • GARDEN SEGMENT GROWTH - Sales growth in Garden segment driven by Wild Bird, Fertilizer and Controls, and Grass Seeds


Company press release: ID:nBw46GWSFa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Miss

$882 mln

$895.76 mln (5 Analysts)

Q3 EPS

$1.45

Q3 Net Income

$90 mln

Q3 Operating Income

Miss

$126 mln

$134.80 mln (4 Analysts)

Q3 Gross Profit

$317 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the food processing peer group is "buy"

  • Wall Street's median 12-month price target for Central Garden & Pet Co is $50.00, about 13.5% above its August 4 closing price of $44.07

  • The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 13 three months ago


Reuters Recommended Reads

  • Aug 5 - Freshpet Q2 revenue tops estimates; raises 2026 outlook

  • Aug 5 - Elanco Animal Health beats Q2 revenue estimates, raises FY guidance

  • Aug 3 - Clorox forecasts upbeat annual sales as demand improves


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Central Garden & Pet

See all news